Daiwa Securities Group Inc. Raises Stock Position in American Healthcare REIT, Inc. (NYSE:AHR)

Daiwa Securities Group Inc. boosted its position in shares of American Healthcare REIT, Inc. (NYSE:AHR - Free Report) by 17.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 334,694 shares of the company's stock after acquiring an additional 50,931 shares during the period. Daiwa Securities Group Inc. owned 0.22% of American Healthcare REIT worth $9,512,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of AHR. Farther Finance Advisors LLC acquired a new position in shares of American Healthcare REIT during the third quarter worth $123,000. Van ECK Associates Corp purchased a new position in American Healthcare REIT during the 3rd quarter worth $363,000. Sigma Planning Corp acquired a new position in American Healthcare REIT during the 3rd quarter valued at about $1,877,000. Axxcess Wealth Management LLC acquired a new stake in American Healthcare REIT in the third quarter worth about $486,000. Finally, State of New Jersey Common Pension Fund D grew its stake in shares of American Healthcare REIT by 57.1% during the third quarter. State of New Jersey Common Pension Fund D now owns 132,000 shares of the company's stock worth $3,445,000 after acquiring an additional 48,000 shares during the last quarter. Hedge funds and other institutional investors own 16.68% of the company's stock.

Analysts Set New Price Targets

AHR has been the subject of several research analyst reports. JMP Securities set a $35.00 price objective on shares of American Healthcare REIT in a research report on Tuesday, March 4th. Royal Bank of Canada raised their price target on shares of American Healthcare REIT from $28.00 to $30.00 and gave the stock an "outperform" rating in a report on Monday, November 18th. Morgan Stanley boosted their price objective on shares of American Healthcare REIT from $27.00 to $29.00 and gave the company an "overweight" rating in a report on Monday, December 30th. Truist Financial raised their target price on American Healthcare REIT from $27.00 to $29.00 and gave the stock a "buy" rating in a research note on Friday, November 15th. Finally, Citigroup reiterated an "outperform" rating on shares of American Healthcare REIT in a research note on Tuesday, March 4th. Eight analysts have rated the stock with a buy rating, According to MarketBeat.com, the company presently has an average rating of "Buy" and a consensus price target of $28.43.

Remove Ads

American Healthcare REIT Stock Performance

NYSE:AHR opened at $28.79 on Wednesday. American Healthcare REIT, Inc. has a fifty-two week low of $12.81 and a fifty-two week high of $30.97. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.37 and a current ratio of 0.37. The company has a 50 day moving average price of $28.51 and a 200 day moving average price of $26.87. The stock has a market capitalization of $4.54 billion and a P/E ratio of -59.97.

American Healthcare REIT Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, January 17th. Investors of record on Tuesday, December 31st were paid a dividend of $0.25 per share. This represents a $1.00 annualized dividend and a yield of 3.47%. The ex-dividend date of this dividend was Tuesday, December 31st. American Healthcare REIT's payout ratio is currently -370.37%.

About American Healthcare REIT

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.